Stephen R. Marks Presents A Gripping Tale of Political Intrigue, Personal Conviction, and Compromised Science in the Epicenter of U.S. Politics

The BRAXTON'S AMERICA trilogy, authored by the acclaimed Stephen R. Marks, offers its readers an enthralling yet light-hearted 3-book series chronicling the unlikely journey of Jonathon Braxton from politically indifferent businessman to disease warfighter and President of the United States.

In this entertaining story, Marks artfully crafts both comedic and serious narratives, combining elements of altruism, political intrigue, the complexities of human emotions and the difficulties of living with Type 1 diabetes. The story of Jonathon Braxton's evolution is one of hope and inspiration for anyone wishing U.S. politics were played differently. And for anyone connected to the Type 1 diabetes community.

BRAXTON'S TURN (Book 1), explores the turn Jon Braxton's life takes, starting in 2012 when he is confronted by the reality his son has contracted a life-threatening disease for which there is no cure. Learning the only source of the money required to advance underfunded diabetes research towards the cure is the U.S government, Braxton hesitantly runs for public office. Jon's breaching the perimeter of U.S politics catapults him on a six-year journey where he completely disrupts Big Pharma and the deep state political machine as they unwillingly bend to his uncompromising will. A journey where he comically alters the trajectory of U.S. politics while guiding both the Republican and Democrat parties to the brink of extinction.

BRAXTON'S PLAN (Book 2) finds Jon in 2017 as the new, and most unusual President of the United States. Unencumbered by greed, ego or the desire to be reelected, he sets the country on a path to cure many things, disease related and not, that ail the nation. First and foremost, Type 1 diabetes. In BRAXTON'S PLAN, Jon solicits the services of his dynamic, black-belted martial arts spouse, to develop and execute a PLAN to bring the world the cure for Type 1 within three years. A PLAN Angela Braxton artfully crafts and puts into motion while Jon maintains his focus on addressing the country's cultural decline.

BRAXTON'S MIRACLE (Book 3) details the second year of the Braxton presidency when the PLAN for the cure for Type 1 is in full swing. But so are the coordinated, diabolical interests of Big Pharma and corrupt politicians to destroy the Braxton's efforts and their administration. Their plot to obliterate everything the Braxton's are working towards twists and turns to the end of the story where the Braxton's defeat their adversaries and the world is finally rewarded with the cure for Type 1 diabetes.

For more information about the book or to connect with Stephen R. Marks , please visit http://www.stephenrmarksauthor.com

About The Author

Stephen R. Marks is an accomplished author known for engaging storytelling and insightful tales. With a penchant for creating intricate worlds and compelling characters, Stephen's works resonate with readers across various genres.

For Media Inquiries:

Stephen R. Marks

Steve@stephenrmarksauthor.com [mailto:Steve@stephenrmarksauthor.com]

Tel 805.443.6388

Media Contact
Company Name: Book Writing Founders
Contact Person: Stephen R. Marks
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stephen-r-marks-presents-a-gripping-tale-of-political-intrigue-personal-conviction-and-compromised-science-in-the-epicenter-of-us-politics]
Country: United States
Website: http://www.stephenrmarksauthor.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.